Thomas Baumert

Company: Alentis Therapeutics

Job title: Founder

Seminars:

Patient-Derived Tumor Spheroids to Model the Tumor Microenvironment & Accelerate Drug Development 9:30 am

Applying patient-derived tumor spheroids to model the tumor immune microenvironment including T cell infiltration and function, tumor fibrosis, CAF and endothelial cell biology Modeling the specific treatment response of compounds on the patient tumor immune environment and cancer epithelial cells using single cell RNASeq and proteomics Understanding how patient-derived tumor spheroids accelerate drug development using…Read more

day: Day 1 AM